Position in LLY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$4,649,460,337
-$294,579,662 QoQ
Shares Held
5,055,025
+9.9% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 99.19654205468815.ToString("F0")%
Shared 0.08528147734185292.ToString("F0")%
None 0.7181764679699902.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Amundi holds $19,301,385,364 across 13 Drug Manufacturers - General names. LLY ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,055,025 | $4,649,460,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,406,820 | $3,277,163,076 | |
| 3 | AZN |
Astrazeneca PLC
|
15,386,149 | $3,034,456,300 | |
| 4 | ABBV |
AbbVie Inc.
|
10,698,095 | $2,326,728,674 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,764,954 | $1,655,786,310 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,539,111 | $1,468,835,897 | |
| 7 | AMGN |
Amgen Inc
|
3,377,306 | $1,188,305,111 | |
| 8 | PFE |
Pfizer Inc
|
40,825,470 | $1,146,379,191 |
All Filings in LLY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,649,460,337 | 5,055,025 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,944,039,999 | 4,600,476 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,453,263,226 | 4,525,902 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,776,083,277 | 3,561,227 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,090,837,929 | 4,953,128 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,388,169,812 | 4,388,821 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $4,021,891,171 | 4,539,688 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,614,538,596 | 3,992,289 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,162,976,070 | 4,065,731 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,184,583,040 | 3,747,655 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,364,292,091 | 4,401,713 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,282,695,887 | 4,867,363 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,951,591,630 | 5,682,813 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,669,701,429 | 4,564,021 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,592,413,052 | 4,924,735 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,221,123,767 | 3,766,227 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $1,068,743,423 | 3,732,037 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $949,679,979 | 3,438,129 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $832,583,819 | 3,603,479 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,008,577,879 | 4,394,292 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||